Charles Ryhee
Stock Analyst at TD Cowen
(1.51)
# 3,143
Out of 4,712 analysts
25
Total ratings
38.1%
Success rate
-6.93%
Average return
Main Sectors:
Stocks Rated by Charles Ryhee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintains: Buy | $73 → $80 | $44.92 | +78.09% | 5 | Nov 25, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Buy | $16 → $14 | $9.68 | +44.63% | 6 | Oct 22, 2024 | |
| MCK McKesson | Maintains: Buy | $563 → $652 | $578.43 | +12.72% | 4 | May 8, 2024 | |
| CVX Chevron | Maintains: Outperform | $185 → $170 | $143.98 | +18.07% | 3 | Feb 24, 2023 | |
| EVH Evolent Health | Maintains: Outperform | $57 → $59 | $11.34 | +420.28% | 2 | Jan 30, 2023 | |
| CAH Cardinal Health | Maintains: Market Perform | $59 → $72 | $119.20 | -39.60% | 1 | Aug 16, 2022 | |
| OTRK Ontrak | Downgrades: Underperform | $3,150 → $810 | $1.48 | +54,815.25% | 2 | Aug 20, 2021 | |
| TDOC Teladoc Health | Maintains: Outperform | $240 → $188 | $9.53 | +1,872.72% | 1 | Aug 9, 2021 | |
| OSCR Oscar Health | Initiates: Market Perform | $29 | $14.19 | +104.37% | 1 | Mar 29, 2021 |
CVS Health
Nov 25, 2024
Maintains: Buy
Price Target: $73 → $80
Current: $44.92
Upside: +78.09%
Walgreens Boots Alliance
Oct 22, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $9.68
Upside: +44.63%
McKesson
May 8, 2024
Maintains: Buy
Price Target: $563 → $652
Current: $578.43
Upside: +12.72%
Chevron
Feb 24, 2023
Maintains: Outperform
Price Target: $185 → $170
Current: $143.98
Upside: +18.07%
Evolent Health
Jan 30, 2023
Maintains: Outperform
Price Target: $57 → $59
Current: $11.34
Upside: +420.28%
Cardinal Health
Aug 16, 2022
Maintains: Market Perform
Price Target: $59 → $72
Current: $119.20
Upside: -39.60%
Ontrak
Aug 20, 2021
Downgrades: Underperform
Price Target: $3,150 → $810
Current: $1.48
Upside: +54,815.25%
Teladoc Health
Aug 9, 2021
Maintains: Outperform
Price Target: $240 → $188
Current: $9.53
Upside: +1,872.72%
Oscar Health
Mar 29, 2021
Initiates: Market Perform
Price Target: $29
Current: $14.19
Upside: +104.37%